BioWorld Science, Cancer

RSS

DX-8951f enters phase I

June 21, 1996

Camptosar approved in U.S.

June 21, 1996

Pierre Fabre reveals cancer treatment agents

June 21, 1996

Bristol-Myers Squibb isolates and synthesizes hayumicin antitumor antibiotics

June 21, 1996

RPR granted rights to Gliadel

June 21, 1996

Grelan to codevelop BioNumerik's BNP-7787

June 14, 1996

Betamipron offers nephrotoxicity protection

June 14, 1996

XR-9051: MDR-reversing agent

June 14, 1996

Fujisawa reveals FR-177391, agent for cachexia in cancer patients

June 14, 1996

PN 27.1 compassionate use trial broadened

June 14, 1996